24小时热门版块排行榜

返回列表

当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖

ph3719

新虫 (初入文坛)

应助: 0 (幼儿园)
金币: 88.5
帖子: 3
在线: 2.6小时
虫号: 831522

[交流] 求助关于利益冲突问题！急

因为文章中列出了一个给我们提供原材料的公司的人QZ，所以PLOS ONE写了EMAIL要求提供利益冲突声明，我们修回后又来信。现在想把QZ列入致谢又怕杂志询问作者本人同意被删除吗？另外，在材料一项中，我们都写成了从产地公司购买的，忘记写成QZ馈赠的了。麻烦在此求助各位，如何去回答。先谢过了！
Dear Dr **,

Thank you for submitting your manuscript entitled "**" to PLoS ONE. Your manuscript files have been checked in house but before we can proceed, we need you to address the following issues:

1) Thank you for submitting your revised paper, and for informing us of the following in your cover letter:

"All authors declare that there are no conflicts of interest and approved to submit to your journal. We also declare that there are no conflicts of interests or financial disclosure, along with employment, consultancy, patents, products in development or marketed products with ** Pharmaceutical Industry Research Institute Co. Ltd. This does not alter our adherence to PLOS ONE policies on sharing data and materials."

We have reviewed this information and would like to suggest the following statements.

Competing interest:
"QZ is an employee of ** Pharmaceutical Industry Research Institute Co. Ltd. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials."

Financial disclosure:
"This work is supported by the National Natural Science Foundation of China (No: **). ** Pharmaceutical Industry Research Institute Co. Ltd., provided support in the form of a salary for author QZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

Please respond by via the cover letter with your approval of the revised statements, if pertinent, alternatively please amend accordingly.

We will change the online submission form on your behalf.

[ Last edited by ph3719 on 2014-2-26 at 21:56 ]

回复此楼